Chariot gears up for summer lithium blitz at Black Mountain
Chariot Corporation has recommenced lithium exploration in Wyoming ERM appointed to assist with 2024 Wyoming exploration activities Drilling will initially utilise a cost-efficient man-portable rig [more…]
US oil producer Brookside Energy’s profits set to gush: Analyst
MST Access values Brookside at a ~400% premium to its current share price NPAT estimate of $40m in FY26 versus a market cap of $55m [more…]
It’s the stupid economy: RBA holds again at 4.35%
At its June meeting the RBA left the cash rate on hold at 4.35% as widely expected, leaving it unchanged now for seven straight months. [more…]
Rise and Shine: Everything you need to know before the ASX opens
Good morning everyone, and welcome to 19 June, 2024 – an important day in the history of things and other stuff. It was on [more…]
AvonWest redefines road freight, logistics and security for Perth’s consumables
AvonWest hub to increase freight efficiency by slashing road train turnaround times Hub will increase supply chain security in Perth Carbon neutral hub to achieve [more…]
FREE WHELAN: Improvised democracy vs reruns of monetary policy
In this Stockhead series, investment manager James Whelan, managing director Barclay Pearce Capital Asset Management, offers his insights on the key investment themes and trends in [more…]
IPO Watch: Is Guzman y Gomez’s ambitious growth story spicy enough for investors?
Guzman y Gomez’s IPO generates buzz, reminiscent of Nuix in 2020 The question is whether the IPO price of $22 is too high Stockhead reaches [more…]
Monsters of Rock: Central banks lust for precious gold and FMG drags the mining sector
World Gold Council says 4 in 5 central banks expect to accumulate more gold in the coming year It The WGC survey follows two record [more…]
Closing Bell: ASX rallies as RBA considers hiking rates; Bitcoin ETF to start trading on Thursday
ASX rose as the RBA held interest rates at 12-year high 4.35pc All 11 sectors on the ASX gained, with significant moves from Pilbara and [more…]
Race Oncology stock gains on US FDA milestone
US FDA extends Rare Paediatric Disease Designation (RPDD) to Race Oncology’s novel RC220 bisantrene drug RPDD gives RC220 eligibility to receive a Priority Review Voucher [more…]
